These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23581707)

  • 1. Emerging neuroprotective effects of N-palmitoylethanolamide besides its significant antinociceptive effects.
    Kapoor S
    Pain Med; 2013 May; 14(5):773-4. PubMed ID: 23581707
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to dr. Kapoor.
    Sabato AF
    Pain Med; 2013 May; 14(5):775. PubMed ID: 23614877
    [No Abstract]   [Full Text] [Related]  

  • 3. Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis.
    Gatti A; Lazzari M; Gianfelice V; Di Paolo A; Sabato E; Sabato AF
    Pain Med; 2012 Sep; 13(9):1121-30. PubMed ID: 22845893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vulvodynia and proctodynia treated with topical baclofen 5 % and palmitoylethanolamide.
    Keppel Hesselink JM; Kopsky DJ; Sajben NL
    Arch Gynecol Obstet; 2014 Aug; 290(2):389-93. PubMed ID: 24691823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical applications of palmitoylethanolamide in pain management: protocol for a scoping review.
    Passavanti MB; Alfieri A; Pace MC; Pota V; Sansone P; Piccinno G; Barbarisi M; Aurilio C; Fiore M
    Syst Rev; 2019 Jan; 8(1):9. PubMed ID: 30621775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Administration of micronized palmitoylethanolamide (PEA)-transpolydatin in the treatment of chronic pelvic pain in women affected by endometriosis: preliminary results].
    Lo Monte G; Soave I; Marci R
    Minerva Ginecol; 2013 Aug; 65(4):453-63. PubMed ID: 24051945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyotrophic lateral sclerosis treatment with ultramicronized palmitoylethanolamide: a case report.
    Clemente S
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):933-6. PubMed ID: 22998138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma.
    Esposito E; Cuzzocrea S
    Mini Rev Med Chem; 2013 Feb; 13(2):237-55. PubMed ID: 22697514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An apPEAling new therapeutic for ulcerative colitis?
    McKernan DP; Finn DP
    Gut; 2014 Aug; 63(8):1207-8. PubMed ID: 24153251
    [No Abstract]   [Full Text] [Related]  

  • 10. Palmitoylethanolamide: biochemistry, pharmacology and therapeutic use of a pleiotropic anti-inflammatory lipid mediator.
    di Marzo V; Skaper SD
    CNS Neurol Disord Drug Targets; 2013 Feb; 12(1):4-6. PubMed ID: 23394521
    [No Abstract]   [Full Text] [Related]  

  • 11. N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress.
    Mattace Raso G; Simeoli R; Russo R; Santoro A; Pirozzi C; d'Emmanuele di Villa Bianca R; Mitidieri E; Paciello O; Pagano TB; Orefice NS; Meli R; Calignano A
    Pharmacol Res; 2013 Oct; 76():67-76. PubMed ID: 23917217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma.
    Paterniti I; Impellizzeri D; Crupi R; Morabito R; Campolo M; Esposito E; Cuzzocrea S
    J Neuroinflammation; 2013 Feb; 10():20. PubMed ID: 23374874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adjuvant use of N-palmitoylethanolamine and transpolydatin in the treatment of endometriotic pain.
    Giugliano E; Cagnazzo E; Soave I; Lo Monte G; Wenger JM; Marci R
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):209-13. PubMed ID: 23415738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of palmitoylethanolamide (PEA) protects the neurovascular unit and reduces secondary injury after traumatic brain injury in mice.
    Ahmad A; Crupi R; Impellizzeri D; Campolo M; Marino A; Esposito E; Cuzzocrea S
    Brain Behav Immun; 2012 Nov; 26(8):1310-21. PubMed ID: 22884901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The palmitoylethanolamide family: a new class of anti-inflammatory agents?
    Lambert DM; Vandevoorde S; Jonsson KO; Fowler CJ
    Curr Med Chem; 2002 Mar; 9(6):663-74. PubMed ID: 11945130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation.
    Esposito G; Capoccia E; Turco F; Palumbo I; Lu J; Steardo A; Cuomo R; Sarnelli G; Steardo L
    Gut; 2014 Aug; 63(8):1300-12. PubMed ID: 24082036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a role for palmitoylethanolamide in the treatment of depression?
    Coppola M; Mondola R
    Med Hypotheses; 2014 May; 82(5):507-11. PubMed ID: 24630855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reply to: "Palmitoylethanolamide: problems regarding micronization, ultra-micronization and additives" Inflammopharmacology DOI:10.1007/s10787-014-0202-3.
    Skaper SD; Facci L; Fusco M; Della Valle MF; Zusso M; Costa B; Giusti P
    Inflammopharmacology; 2015 Jun; 23(2-3):127-30. PubMed ID: 24862356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palmitoylethanolamide: from endogenous cannabimimetic substance to innovative medicine for the treatment of cannabis dependence.
    Coppola M; Mondola R
    Med Hypotheses; 2013 Oct; 81(4):619-22. PubMed ID: 23896215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections.
    Redlich S; Ribes S; Schütze S; Nau R
    J Neuroinflammation; 2014 Jun; 11():108. PubMed ID: 24927796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.